Literature DB >> 12124937

A contribution to breast cancer cell proteomics: detection of new sequences.

Ida Pucci-Minafra1, Simona Fontana, Patrizia Cancemi, Loredana Basiricò, Silvana Caricato, Salvatore Minafra.   

Abstract

Ductal infiltrating carcinoma (DIC) of the breast is the most common and potentially aggressive form of cancer. Knowledge of proteomic profiles, attained both in vivo and in vitro, is fundamental to acquire as much information as possible on the proteins expressed in these pathologic conditions. We used the breast cancer cell line 8701-BC, established from a primary DIC, with the aim of contributing to the databases on mammary cancer cells, which in turn will be very useful for the identification of differentially expressed proteins in normal and neoplastic cells. Within an analysis window comprising about 1750 discernible spots, we have at present catalogued 84 protein spots. The proteins for which an identity was assigned were identified essentially using gel comparison, N-terminal (Nt) microseqencing and immune detection. Among the protein spots Nt-microsequenced, sixteen corresponded to known proteins, four resulted as modified, relative to matching sequences deposited on databases, and seven were unknown. These modified or novel sequences are thus of potential interest to the knowledge of breast cancer proteomics and its applications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124937     DOI: 10.1002/1615-9861(200207)2:7<919::AID-PROT919>3.0.CO;2-P

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  6 in total

1.  Large-scale proteomic identification of S100 proteins in breast cancer tissues.

Authors:  Patrizia Cancemi; Gianluca Di Cara; Nadia Ninfa Albanese; Francesca Costantini; Maria Rita Marabeti; Rosa Musso; Carmelo Lupo; Elena Roz; Ida Pucci-Minafra
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

2.  In vitro phenotypic, genomic and proteomic characterization of a cytokine-resistant murine β-TC3 cell line.

Authors:  Antonina Coppola; Laura Tomasello; Giuseppe Pizzolanti; Ida Pucci-Minafra; Nadia Albanese; Gianluca Di Cara; Patrizia Cancemi; Maria Pitrone; Alessandra Bommarito; Elvira Carissimi; Giovanni Zito; Angela Criscimanna; Aldo Galluzzo; Carla Giordano
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

3.  Retrospective Proteomic Screening of 100 Breast Cancer Tissues.

Authors:  Ida Pucci-Minafra; Gianluca Di Cara; Rosa Musso; Patrizia Cancemi; Nadia Ninfa Albanese; Elena Roz; Salvatore Minafra
Journal:  Proteomes       Date:  2017-07-07

4.  Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation.

Authors:  Miriam Buttacavoli; Nadia Ninfa Albanese; Gianluca Di Cara; Rosa Alduina; Claudia Faleri; Michele Gallo; Giuseppe Pizzolanti; Giuseppe Gallo; Salvatore Feo; Franco Baldi; Patrizia Cancemi
Journal:  Oncotarget       Date:  2017-12-23

5.  Proteomic Profiling of Colon Cancer Tissues: Discovery of New Candidate Biomarkers.

Authors:  Miriam Buttacavoli; Nadia Ninfa Albanese; Elena Roz; Ida Pucci-Minafra; Salvatore Feo; Patrizia Cancemi
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

6.  A multiomics analysis of S100 protein family in breast cancer.

Authors:  Patrizia Cancemi; Miriam Buttacavoli; Gianluca Di Cara; Nadia Ninfa Albanese; Serena Bivona; Ida Pucci-Minafra; Salvatore Feo
Journal:  Oncotarget       Date:  2018-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.